Opioid Treatment Access Act of 2022 This bill expands access to substance use disorder treatment by modifying the regulation of opioid treatment programs and narcotic drugs used for treatment, including with respect to a patient's unsupervised use of such drugs. Specifically, the Department of Health and Human Services (HHS) must issue regulations to further increase patients' access to unsupervised use or handling of drugs for treatment. The Substance Abuse and Mental Health Services Administration (SAMHSA) must study the effects of these revisions, and HHS must, as appropriate, promulgate additional regulations based on the study's findings. SAMHSA must also study the impact of certain exemptions from certification requirements for opioid treatment programs that were granted as part of COVID-19 response efforts, including any additional costs or savings that resulted from the exemptions. The bill also (1) allows specified types of health care providers to prescribe (subject to certain requirements) methadone that is dispensed through pharmacies for a patient's unsupervised use, and (2) provides statutory authority for a regulation that allows registered opioid treatment programs to operate mobile medication units without separately registering the unit.
Sponsored bills
Maddy summaryThis bill (SJRES 36) prohibits a specific proposed U.S. defense sale to Egypt. It blocks the transfer of certain defense articles and services, including three SPS-48 Land Based Radar systems, related spare parts, technical support, and training, as detailed in a January 2022 government transmittal. The resolution directly affects the Egyptian government by preventing this particular military transaction. It operates under the Arms Export Control Act, requiring congressional disapproval to halt the sale.
Accelerated Drug Approval for Prescription Therapies 2.0 Act or the ADAPT 2.0 Act This bill allows applicants seeking Food and Drug Administration (FDA) approval to market a new drug to rely on investigations conducted in certain other countries and addresses related issues. If an applicant seeks market approval for a new drug with an application that relies on at least one investigation that the applicant did not conduct and did not obtain approval to use, the applicant may rely on an investigation that was conducted in certain foreign countries if the drug in question has already been approved in that country. The investigation must have been conducted in Australia, Canada, Israel, Japan, New Zealand, Switzerland, South Africa, the United Kingdom, the European Union, a country in the European Economic Area, or another country that the FDA has found to meet certain requirements. The FDA must make a decision on such an application within 90 days of the application's filing. If the FDA does not take certain actions within that period, the application shall be considered approved. The FDA may require the applicant to conduct postapproval studies of the drug and to submit copies of all promotional materials. The bill also establishes an advisory committee to provide the FDA with recommendations as to each application that relies on a foreign investigation. The FDA must make available on its public website each decision on such an application, including the rationale for the decision and the advisory committee's recommendations.
OSHA ETS Clarification Act of 2022 This bill limits the scope of the Department of Labor's authority to issue emergency temporary standards concerning safety and health to dangers or hazards specific to the workplace. Currently, Labor may issue an emergency standard upon determining that (1) employees are exposed to a new danger or hazard, and (2) the emergency standard is necessary to protect employees. Under this bill, Labor must also determine that the danger or hazard arises exclusively from or is specific to the workplace covered by the emergency standard.
Federal Prisons Accountability Act of 2022 This bill modifies the appointment procedures and term of service for the Director of the Bureau of Prisons. Currently, the director is appointed by the Attorney General. This bill requires the director to be appointed by the President and confirmed by the Senate. The bill also limits the director to a single term of 10 years.
Restore Parental and Consumer Medical Rights in the Nation's Capital Act This bill nullifies the following actions of the government of the District of Columbia: Order 2021-148 issued by the Mayor on December 22, 2021 (relating to vaccination requirements for entrance into certain indoor establishments and facilities); and the Coronavirus Immunization of School Students and Early Childhood Workers Amendment Act of 2021 (D.C. Act 24-285), enacted by the District of Columbia Council on January 12, 2022.
National Right-to-Work Act This bill repeals those provisions of the National Labor Relations Act and the Railway Labor Act that permit employers to make an agreement with a labor union to require employees to join such union as a condition of employment. Currently, 28 states have enacted laws prohibiting employers from compelling employees to become members of a union as a condition of employment.
Preventing Violence Against Female Inmates Act of 2022 This bill establishes a framework to prohibit correctional institutions at the federal and state levels from using gender identity to house inmates of one biological sex with inmates of the other biological sex.
Maddy summarySRES 485 is a Senate resolution honoring the late Senator Harry Mason Reid, Jr., of Nevada, who died in 2021. The resolution expresses the Senate's sorrow at his passing, extends condolences to his family, and directs the Secretary of the Senate to communicate the resolution to the House of Representatives and provide a copy to Reid's family. The Senate also adjourned in his memory as a mark of respect. This is a ceremonial tribute with no policy changes or legal effect.
Maddy summarySRES 484 is a ceremonial Senate resolution honoring the late Senator John "Johnny" Isakson of Georgia. It formally recognizes his 40+ years of public service, including his roles in the Georgia legislature, U.S. House, and U.S. Senate, and his reputation for bipartisan cooperation. The resolution requests the Senate Secretary communicate it to the House and send a copy to Isakson's family. As a commemorative resolution, it has no policy impact or direct effect on any individuals or programs.